Home > Cancer and Treatments > Pancreatic Cancer

Pancreatic Cancer Clinical Trials

Clinical trials are research studies that play a key role in finding better ways to treat cancer.

The following is a list of pancreatic cancer clinical trials studying:

Operable cancer (resectable) or border-line operable

UMCC 2006.025HUM00004531:
A Multi-Institutional Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin with Radiation Therapy in Patients with Pancreatic Cancer. For more information about this study, read about it on the Engage web site or call Janet Hampton OCN, RN 734-615-8839.

Locally advanced disease (disease that has not spread)

UMCC 2006.018HUM00003315:
A Phase I/II Radiation Dose-Escalation Study of Intensity-Modulated Radiotherapy (IMRT) with Concurrent Gemcitabine in Patients with Unresectable Pancreatic Cancer. For more information about this study, read about it on the Engage web site or call Janet Hampton OCN, RN 734-615-8839.

Metastatic disease (disease that has spread)

no studies at this time.

Last update 11/2008

Adjust text size